CHM

0.00%

1.0¢ chimeric therapeutics limited

How's the Capital Raise Going to Work?, page-2

First 2 Last

Share
Profile

Follow
dalts66

4,436 Posts.

2059

15/03/23

10:31

Post #: 66772708
Share

Originally posted by fourdollars: ↑

CHM is burning around $5m per quarter. Even with the recent R&D tax rebate, it has less than 2 quarters of funding remaining.

The L1 facility requires that CHM issues shares at a discount to the VWAP of 5 of the previous 30 trading days (selected by L1), so whatever the exact price, its looking like it will be under 7cps.

Current shares on issue: 437m

Raising $30m at 7cps = 429m shares. Plus L1 were already issued 5m shares back in June last year when the funding arrangement was announced. This would leave L1 with approx 50% of the company. I don't think any shareholder can take such a large position without the approval of other shareholders, so not sure how this can work?

The L1 funding agreement announcement did note: "Equity placement facility of up to a total of A$30 million over 24 months with L1 Capital ..... by way of separate placements (the size of whichare subject to certain limits)"

Maybe this is what the clause alludes to - ie there are certain limits to the number of shares that can be issued.

But even if this was capped to under 20% of the company, over 100m shares would still be issued to L1. This would only raise $7m, and not even cover a further 2 quarters of cashburn at CHM. Also, there is the possibility that L1 won't feel comfortable owing such a large percentage of CHM, leading to SP pressure as it reduces its position.

So does Hopper pursue the usual Bell Potter / sophisticated biotech investor route, where he issues discounted shares to nameless entities along with millions of free options? Its been his modus operandi at Imugene, but the last two capital raises there are so far under water it might not be an easy sell here. Might require issuing shares at a massive discount (sub 4c?), and possibly also result is a significant share overhang that puts further downward pressure on the SP.

Hard to see how CHM can be funded for much longer without a huge dilution ....

Expand

If the readout of the 3rd cohort shows promise of disease control or better. we may have the 1st CarT drug that can tackle solid tumour cancer.

That may be the catalyst you are looking for. Remember that the NK trial underway now is of no cost to CHM.

Luckily CHM is run by a group of highly experienced folk. This is not their first rodeo.With the tiny SOI now, and incredibly low market cap for its pipeline. even with dilution now, thd potential of many multiples of upside is still available.

CHM Price at posting: 6.5¢ Sentiment: Buy Disclosure: Held
14 Upvote

2 Great analysis

Reply

Top Stories

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

HotCopper Highlights: Your most watched stocks for Week 46, 2024

There are more pages in this discussion • 19 more messages in this thread...

First 2 Last

Add CHM (ASX) to my watchlist

(20min delay)
Last 1.0¢		Change 0.000(0.00%)		Mkt cap ! $9.951M

Open	High	Low	Value	Volume
1.1¢	1.1¢	1.0¢	$30.25K	3.010M

Buyers (Bids)

No.	Vol.	Price($)
8	1600735	1.0¢

Sellers (Offers)

Price($)	Vol.	No.
1.1¢	545477	5

View Market Depth

No.	Vol.	Price($)
7	1300735	0.010
19	5134142	0.009
20	6501003	0.008
15	5983427	0.007
5	1744766	0.006

Price($)	Vol.	No.
0.011	545477	5
0.012	967491	4
0.013	153846	1
0.014	655016	2
0.015	579596	1

Last trade - 15.59pm 15/11/2024 (20 minute delay)

CHM (ASX) Chart

How's the Capital Raise Going to Work?, page-2

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Banshee's historic trenches prove rich in antimony and gold for GDM

Cyclone signs MOU with Vale for development of Iron Bear play

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

How's the Capital Raise Going to Work?, page-2

Top Stories

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Banshee's historic trenches prove rich in antimony and gold for GDM

Cyclone signs MOU with Vale for development of Iron Bear play

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News